Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance

Stroke

Volumn 39, Issue 11, 2008, Pages 3042-3048

  Chen, Min ^a   Lu, Ting Jia ^a   Chen, Xiao Jing ^a   Zhou, Yang ^a   Chen, Qian ^a   Feng, Xiao Yan ^a   Xu, Li ^a   Duan, Wen Hu ^b   Xiong, Zhi Qi ^a,c  

^a Institute of Neuroscience   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c NONE   (China)

Author keywords

CREB; Ifenprodil; Ischemic tolerance; NMDA receptor; NVP AAM077; Transient global ischemia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IFENPRODIL; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; 5 (ALPHA METHYL 4 BROMOBENZYLAMINO)PHOSPHONOMETHYL 1,4 DIHYDROQUINOXALINE 2,3 DIONE; 5-(ALPHA-METHYL-4-BROMOBENZYLAMINO)PHOSPHONOMETHYL-1,4-DIHYDROQUINOXALINE-2,3-DIONE; AMINO ACID RECEPTOR BLOCKING AGENT; CPG15 PROTEIN, RAT; ISOPROTEIN; MEMBRANE PROTEIN; NERVE PROTEIN; NR2A NMDA RECEPTOR; NR2B NMDA RECEPTOR; PIPERIDINE DERIVATIVE; QUINOXALINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NERVE CELL NECROSIS; NEUROPROTECTION; NISSL STAINING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL DEATH; CYTOLOGY; GENETICS; HUMAN; ISCHEMIC PRECONDITIONING; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DEATH; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; ISCHEMIC PRECONDITIONING; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NEURONS; PIPERIDINES; PROTEIN ISOFORMS; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 55749108180     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.521898     Document Type: Article

References (41)

1. Ozyurt E, Graham DI, Woodruff GN, McCulloch J. Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat. J Cereb Blood Flow Metab. 1988;8:138-143.
2. Bossy-Wetzel E, Talantova MV, Lee WD, Scholzke MN, Harrop A, Mathews E, Gotz T, Han J, Ellisman MH, Perkins GA, Lipton SA. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated k+ channels. Neuron. 2004;41:351-365.
3. Grabb MC, Choi DW. Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J Neurosci. 1999;19:1657-1662.
4. Feng Z, Davis DP, Sasik R, Patel HH, Drummond JC, Patel PM. Pathway and gene ontology based analysis of gene expression in a rat model of cerebral ischemic tolerance. Brain Res. 2007;1177:103-123.
5. Kato H, Liu Y, Araki T, Kogure K. MK-801, but not anisomycin, inhibits the induction of tolerance to ischemia in the gerbil hippocampus. Neurosci Lett. 1992;139:118-121.
6. Wrang ML, Diemer NH. MK-801 does not prevent development of ischemic tolerance in rat brain. Neuroreport. 2004;15:1151-1155.
7. Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat Neurosci. 2002;5(suppl):1039-1042.
8. Birmingham K. Future of neuroprotective drugs in doubt. Nat Med. 2002;8:5.
9. Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 2002; 1:383-386.
10. Chatterton JE, Awobuluyi M, Premkumar LS, Takahashi H, Talantova M, Shin Y, Cui J, Tu S, Sevarino KA, Nakanishi N, Tong G, Lipton SA, Zhang D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 2002;415:793-798.
11. McBain CJ, Mayer ML. N-methyl-d-aspartic acid receptor structure and function. Physiol Rev. 1994;74:723-760.
12. Ikeda K, Nagasawa M, Mori H, Araki K, Sakimura K, Watanabe M, Inoue Y, Mishina M. Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel. FEBS Lett. 1992;313:34-38.
13. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M, et al. Molecular diversity of the NMDA receptor channel. Nature. 1992;358:36-41.
14. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 1992;256: 1217-1221.
15. Laurie DJ, Bartke I, Schoepfer R, Naujoks K, Seeburg PH. Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res Mol Brain Res. 1997;51:23-32.
16. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 1994;12:529-540.
17. Chen Q, He S, Hu XL, Yu J, Zhou Y, Zheng J, Zhang S, Zhang C, Duan WH, Xiong ZQ. Differential roles of NR2A- and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. J Neurosci. 2007;27: 542-552.
18. Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, Auberson YP, Wang YT. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science. 2004;304: 1021-1024.
19. Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci. 2007;27:2846-2857.
20. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol. 1982;11: 491-498.
21. Auberson YP, Allgeier H, Bischoff S, Lingenhoehl K, Moretti R, Schmutz M. 5-phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1a/2a, rather than 1a/2b receptor composition. Bioorg Med Chem Lett. 2002;12: 1099-1102.
22. Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature. 1999;399:A7-A14.
23. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330:613-622.
24. Simon RP, Swan JH, Griffiths T, Meldrum BS. Blockade of n-methyl-d-aspartate receptors may protect against ischemic damage in the brain. Science. 1984;226:850-852.
25. Tanaka H, Yokota H, Jover T, Cappuccio I, Calderone A, Simionescu M, Bennett MV, Zukin RS. Ischemic preconditioning: neuronal survival in the face of caspase-3 activation. J Neurosci. 2004;24:2750 -2759.
26. Hara T, Hamada J, Yano S, Morioka M, Kai Y, Ushio Y. CREB is required for acquisition of ischemic tolerance in gerbil hippocampal ca1 region. J Neurochem. 2003;86:805-814.
27. Mabuchi T, Kitagawa K, Kuwabara K, Takasawa K, Ohtsuki T, Xia Z, Storm D, Yanagihara T, Hori M, Matsumoto M. Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J Neurosci. 2001;21:9204-9213.
28. Sheng M, Kim MJ. Postsynaptic signaling and plasticity mechanisms. Science. 2002;298:776-780.
29. Kim MJ, Dunah AW, Wang YT, Sheng M. Differential roles of NR2A-and NR2B-containing NMDA receptors in RAS-ERK signaling and AMPA receptor trafficking. Neuron. 2005;46:745-760.
30. Li R, Huang FS, Abbas AK, Wigstrom H. Role of NMDA receptor subtypes in different forms of NMDA-dependent synaptic plasticity. BMC Neurosci. 2007;8:55.
31. Stocca G, Vicini S. Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J Physiol. 1998;507: 13-24.
32. Tovar KR, Westbrook GL. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci. 1999;19:4180-4188.
33. Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002;5:405-414.
34. Sattler R, Xiong Z, Lu WY, MacDonald JF, Tymianski M. Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity. J Neurosci. 2000;20:22-33.
35. Kirino T, Tamura A, Sano K. Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol. 1984;64:139-147.
36. Bond A, Lodge D, Hicks CA, Ward MA, O'Neill MJ. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus. Eur J Pharmacol. 1999; 380:91-99.
37. Barone FC, White RF, Spera PA, Ellison J, Currie RW, Wang X, Feuerstein GZ. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke. 1998; 29:1937-1950; discussion 1950-1951.
38. Miao B, Yin XH, Pei DS, Zhang QG, Zhang GY. Neuroprotective effects of preconditioning ischemia on ischemic brain injury through down-regulating activation of JNK1/2 via n-methyl-d-aspartate receptor-mediated AKT1 activation. J Biol Chem. 2005;280:21693-21699.
39. Wang RM, Yang F, Zhang YX. Preconditioning-induced activation of ERK5 is dependent on moderate CA2 + influx via NMDA receptors and contributes to ischemic tolerance in the hippocampal CA1 region of rats. Life Sci. 2006;79:1839-1846.
40. FujinoT, Lee WC, NediviE. Regulation of CPG15 by signaling pathways that mediate synaptic plasticity. Mol Cell Neurosci. 2003;24:538-554.
41. Putz U, Harwell C, Nedivi E. Soluble CPG15 expressed during early development rescues cortical progenitors from apoptosis. Nat Neurosci. 2005;8:322-331.